| Ms Kristin Lynn Blank, OTR/L | |
|
18 Professional Village Cir, Beaufort, SC 29907-1570 | |
| (843) 986-9670 | |
| Not Available |
| Full Name | Ms Kristin Lynn Blank |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapy |
| Experience | 16 Years |
| Location | 18 Professional Village Cir, Beaufort, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831419803 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XP0200X | Occupational Therapist - Pediatrics | OC010796 (Pennsylvania) | Secondary |
| 225XH1200X | Occupational Therapist - Hand | 4418 (South Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Optim Orthopedics Llc | 9931427002 | 85 |
News Archive
New evidence published today in the Cochrane Library shows that hormone replacement therapy does not protect post-menopausal women against cardiovascular disease, and may even cause an increased risk of stroke.
Rockwell Medical, a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ESRD), chronic kidney disease (CKD), and iron deficiency anemia, announced today that Phase IIb data for its lead drug candidate Soluble Ferric Pyrophosphate (SFP) have been accepted for presentation at the XLVII European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Congress, organized in collaboration with the Deutsche Gesellschaft fur Nephrologie (DGfN) in Munich, Germany, June 25-28, 2010.
Relmada Therapeutics Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced a positive outcome of its pivotal pharmacokinetic study for LevoCap ER. Based on the positive outcome of this study, Relmada is now preparing the Phase III development program and is planning to submit a request with the FDA to discuss the final pathway to the New Drug Application for this product during the fourth quarter of this year.
The American Dental Association (ADA) is extending invitations to those concerned about the oral health of vulnerable older adults and people with disabilities to attend a national conference and help shape the future of oral health care for this underserved and growing population.
› Verified 1 days ago
| Provider Name | Optim Orthopedics Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1528451481 PECOS PAC ID: 9931427002 Enrollment ID: O20150421002671 |
News Archive
New evidence published today in the Cochrane Library shows that hormone replacement therapy does not protect post-menopausal women against cardiovascular disease, and may even cause an increased risk of stroke.
Rockwell Medical, a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ESRD), chronic kidney disease (CKD), and iron deficiency anemia, announced today that Phase IIb data for its lead drug candidate Soluble Ferric Pyrophosphate (SFP) have been accepted for presentation at the XLVII European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Congress, organized in collaboration with the Deutsche Gesellschaft fur Nephrologie (DGfN) in Munich, Germany, June 25-28, 2010.
Relmada Therapeutics Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced a positive outcome of its pivotal pharmacokinetic study for LevoCap ER. Based on the positive outcome of this study, Relmada is now preparing the Phase III development program and is planning to submit a request with the FDA to discuss the final pathway to the New Drug Application for this product during the fourth quarter of this year.
The American Dental Association (ADA) is extending invitations to those concerned about the oral health of vulnerable older adults and people with disabilities to attend a national conference and help shape the future of oral health care for this underserved and growing population.
› Verified 1 days ago
| Provider Name | Gravity Physical Therapy Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1710363999 PECOS PAC ID: 4789984832 Enrollment ID: O20151123000935 |
News Archive
New evidence published today in the Cochrane Library shows that hormone replacement therapy does not protect post-menopausal women against cardiovascular disease, and may even cause an increased risk of stroke.
Rockwell Medical, a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ESRD), chronic kidney disease (CKD), and iron deficiency anemia, announced today that Phase IIb data for its lead drug candidate Soluble Ferric Pyrophosphate (SFP) have been accepted for presentation at the XLVII European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Congress, organized in collaboration with the Deutsche Gesellschaft fur Nephrologie (DGfN) in Munich, Germany, June 25-28, 2010.
Relmada Therapeutics Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced a positive outcome of its pivotal pharmacokinetic study for LevoCap ER. Based on the positive outcome of this study, Relmada is now preparing the Phase III development program and is planning to submit a request with the FDA to discuss the final pathway to the New Drug Application for this product during the fourth quarter of this year.
The American Dental Association (ADA) is extending invitations to those concerned about the oral health of vulnerable older adults and people with disabilities to attend a national conference and help shape the future of oral health care for this underserved and growing population.
› Verified 1 days ago
| Provider Name | Cora South Carolina Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1164923355 PECOS PAC ID: 3173766334 Enrollment ID: O20180326002748 |
News Archive
New evidence published today in the Cochrane Library shows that hormone replacement therapy does not protect post-menopausal women against cardiovascular disease, and may even cause an increased risk of stroke.
Rockwell Medical, a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ESRD), chronic kidney disease (CKD), and iron deficiency anemia, announced today that Phase IIb data for its lead drug candidate Soluble Ferric Pyrophosphate (SFP) have been accepted for presentation at the XLVII European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Congress, organized in collaboration with the Deutsche Gesellschaft fur Nephrologie (DGfN) in Munich, Germany, June 25-28, 2010.
Relmada Therapeutics Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced a positive outcome of its pivotal pharmacokinetic study for LevoCap ER. Based on the positive outcome of this study, Relmada is now preparing the Phase III development program and is planning to submit a request with the FDA to discuss the final pathway to the New Drug Application for this product during the fourth quarter of this year.
The American Dental Association (ADA) is extending invitations to those concerned about the oral health of vulnerable older adults and people with disabilities to attend a national conference and help shape the future of oral health care for this underserved and growing population.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Kristin Lynn Blank, OTR/L 2682 Broad St, Beaufort, SC 29902-6371 Ph: (717) 404-2730 | Ms Kristin Lynn Blank, OTR/L 18 Professional Village Cir, Beaufort, SC 29907-1570 Ph: (843) 986-9670 |
News Archive
New evidence published today in the Cochrane Library shows that hormone replacement therapy does not protect post-menopausal women against cardiovascular disease, and may even cause an increased risk of stroke.
Rockwell Medical, a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ESRD), chronic kidney disease (CKD), and iron deficiency anemia, announced today that Phase IIb data for its lead drug candidate Soluble Ferric Pyrophosphate (SFP) have been accepted for presentation at the XLVII European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Congress, organized in collaboration with the Deutsche Gesellschaft fur Nephrologie (DGfN) in Munich, Germany, June 25-28, 2010.
Relmada Therapeutics Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced a positive outcome of its pivotal pharmacokinetic study for LevoCap ER. Based on the positive outcome of this study, Relmada is now preparing the Phase III development program and is planning to submit a request with the FDA to discuss the final pathway to the New Drug Application for this product during the fourth quarter of this year.
The American Dental Association (ADA) is extending invitations to those concerned about the oral health of vulnerable older adults and people with disabilities to attend a national conference and help shape the future of oral health care for this underserved and growing population.
› Verified 1 days ago
Spencer Reyes, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 35 Parris Island Gtwy Unit 198, Beaufort, SC 29906 Phone: 843-575-4722 | |
Mr. Jesse Ausec, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 103 Prescott Dr, Beaufort, SC 29902 Phone: 770-307-8723 | |
Emily M E Kimmins, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1600 Washington St, Beaufort, SC 29902 Phone: 843-812-1958 | |
Grace Reyes, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 35 Parris Island Gtwy Unit 198, Beaufort, SC 29906 Phone: 843-575-4722 | |
Mrs. Julia B Hetherington, MHS OTR CHT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 18 Professional Village Circle, Beaufort, SC 29907 Phone: 843-521-9673 Fax: 843-986-9369 | |
Christina Witt Gordon, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 18 Professional Village Cir, Beaufort, SC 29907 Phone: 843-986-9670 Fax: 843-986-9369 | |
Laurie Boggus Martin, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 296 Broad River Dr, Beaufort, SC 29906 Phone: 843-252-1534 |